Trial Profile
A Dose Escalation Study to Evaluate the Effect of Inhaled Nitrite on Cardiopulmonary Hemodynamics in Subjects With Pulmonary Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sodium nitrite (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 20 Jul 2018 Status changed from recruiting to completed.
- 23 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 23 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.